Delivery Order SPE2DR25D1017-SPE2DR26F9DEY
Award Date 1/14/26
Potential Completion Date 1/15/26
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme supplement) in 100-count bottles, with a ceiling value of $17,158.94. This firm fixed-price delivery order, issued on December 5, 2025, with completion expected by December 8, 2025, represents a non-competitive, non-set-aside award under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA. The pharmaceutical will be supplied from the...
- The Defense Logistics Agency awarded a delivery order valued at $1,916.10 to AmerisourceBergen Drug Corp for the supply of Creon DR 36,000 unit capsules (100 count) on January 12, 2026, with completion scheduled for January 13, 2026. This non-competitive delivery order utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 24,000 unit capsules of Creon (pancrelipase) in 100-unit quantities, valued at $1,072.14. This non-competitive, firm fixed-price delivery order was awarded on January 2, 2026, with an ultimate completion date of January 5, 2026. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp on January 9, 2026, for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count bottles, with a ceiling value of $14,266.09 and an ultimate completion date of January 12, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award falls under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $9,903.51 delivery order to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) on September 24, 2025, with an ultimate completion date of September 25, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement medication, with a ceiling value of $2,979.09. This is a firm fixed price delivery order with an ultimate completion date of December 3, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,982.70 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement therapy. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement with an ultimate completion date of December 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and serve as the prime contractor for this...
- The Defense Logistics Agency awarded a $17,441.40 delivery order to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count bottles, with an ultimate completion date of December 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $27,202.55 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) on January 7, 2026, with an ultimate completion date of January 8, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora,...
- The Defense Logistics Agency awarded a delivery order valued at $4,292.79 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules on January 2, 2026, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price delivery order represents a routine pharmaceutical procurement with no set-aside designation. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...